Reitan Colleen F
SEC CIK 1740730 · EDGAR
BoughtSold
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
| 15 | Reitan Colleen F | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 16:25 | 2026-06-04 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | A - Grant | $0.00 | +59.7K | 152.0K | +65% | $0 | |
| D | 2026-05-22 16:16 | 2026-05-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | A - Grant | $0.00 | +671 | 1,446 | +87% | $0 |
| DM | 2025-09-11 | 2025-09-09 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | S - Sale+OE | $467.60 | -18.0K | 5,791 | -76% | -$8.42M |
| D | 2025-09-11 | 2025-09-09 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | M - OptEx | $100.65 | +18.0K | 18.8K | +2,323% | +$1.81M |
| 2025-06-06 | 2025-06-05 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | A - Grant | $0.00 | +49.8K | 92.3K | +117% | $0 | |
| DM | 2025-05-12 | 2024-08-29+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | P - Purchase | $287.85 | +36 | 36 | New | +$10.4K |
| D | 2025-05-12 | 2025-04-16 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | S - Sale | $232.86 | -36 | 0 | -100% | -$8,383 |
| D | 2025-05-12 | 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| 2024-09-04 | 2024-09-03 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | S - Sale | $27.95 | -46.0K | 42.5K | -52% | -$1.29M | |
| 2024-06-07 | 2024-06-06 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | A - Grant | $0.00 | +15.7K | 88.5K | +22% | $0 | |
| 2023-06-02 | 2023-06-01 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | A - Grant | $0.00 | +15.2K | 72.8K | +26% | $0 | |
| 2022-06-03 | 2022-06-02 | MYGN | MYRIAD GENETICS INC | Reitan Colleen F | Dir | A - Grant | $0.00 | +17.3K | 57.7K | +43% | $0 |
Purchase Sale Sale after option exercise All abbreviations